Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study

✍ Scribed by Corrie, Pippa G; Marshall, Andrea; Dunn, Janet A; Middleton, Mark R; Nathan, Paul D; Gore, Martin; Davidson, Neville; Nicholson, Steve; Kelly, Charles G; Marples, Maria; Danson, Sarah J; Marshall, Ernest; Houston, Stephen J; Board, Ruth E; Waterston, Ashita M; Nobes, Jenny P; Harries, Mark; Kumar, Satish; Young, Gemma; Lorigan, Paul

• Book ID: 122283473
• Publisher: The Lancet
• Year: 2014
• Tongue: English
• Weight: 361 KB
• Volume: 15
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(14)70110-X